title: Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia.
authors.affiliation: M.D. Anderson Cancer Center, Houston, TX
  hkantarjian@mdanderson.org
authors.forename: Hagop M
authors.initials: HM
authors.lastname: Kantarjian
authors.affiliation: Pfizer, Cambridge, MA
authors.forename: Erik
authors.initials: E
authors.lastname: Vandendries
authors.affiliation: Cleveland Clinic, Cleveland, OH
authors.forename: Anjali S
authors.initials: AS
authors.lastname: Advani
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized